Altasciences Featured Articles

  1. Cytokine Data Evaluation In NHP Safety Studies: Correlation To Toxicity Outcomes 2/25/2025

    This cytokine data in conjunction with other clinical findings was used to improve the accuracy of toxicity assessments, the timing of measurements, and the specific cytokines involved.

  2. Historical Control Reference Values for Cambodian Cynomolgus Macaque Blood Gases 2/25/2025

    Utilize the provided baseline blood gas data for cynomolgus macaques to enhance the assessment of drug-related respiratory effects and improve the accuracy of respiratory safety evaluations.

  3. Comparing Cytokine Data To In-Life Parameters On NHPs In Nonclinical Studies 2/25/2025

    Incorporate cytokine measurements alongside clinical observations, body weights, and clinical pathology data to enhance the accuracy of immunotoxicity assessments and improve safety evaluations.

  4. Acute Dermal Irritation Response In White Sinclair And Hanford Miniature Swine 2/25/2025

    Utilize our acute dermal irritation model in white Sinclair and Hanford miniature swine to reliably assess irritation responses and optimize compound selection for dermatological research and safety.

  5. Dermal Toxicology Changes In Hanford Miniature Swine Over 18 Weeks 2/25/2025

    Our findings confirm that the Spector method provides a reliable and valid approach for TBSA calculations in juvenile miniature swine.

  6. Development Of A Model Of Urticaria In Miniature Swine 2/25/2025

    See how we successfully established a histamine-induced urticaria model, providing a reliable platform for evaluating the efficacy of topical treatments for urticaria and other skin conditions.

  7. Geometric Determinants Of Full-Thickness Wound Healing 2/25/2025

    Our findings confirm that Yucatan miniature swine provides a reliable and predictive model for preclinical wound healing studies.

  8. Why Use Miniature Swine In Dermal Research? 2/25/2025

    Miniature swine models offer researchers an invaluable, reliable, and predictive tool for dermal research, making them essential for advancing novel cutaneous therapies.

  9. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  10. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.